-
1Report
المصدر: A Phase II Study Evaluating Reduced Starting Dose and Dose Escalation of Cabozantinib As Second-line Therapy for Advanced HCC in Patients with Preserved Liver Function
المصدر: A Phase II Study Evaluating Reduced Starting Dose and Dose Escalation of Cabozantinib As Second-line Therapy for Advanced HCC in Patients with Preserved Liver Function